| Enrolling By Invitation | Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring Health Prognosis, Fertility, Breast Cancer | — | 2026-01-01 |
| Completed | Enhancing Critical Thinking Competency and Nursing Quality in Critically Ill Patient Care Evidence-Based Nursing, Critically Ill Patient, Training | N/A | 2025-05-25 |
| Not Yet Recruiting | Establishment and Clinical Application of Breast Cancer Risk Prediction Model Based on Traditional Chinese Med Breast Cancer Screening | — | 2025-04-26 |
| Not Yet Recruiting | Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell SCLC, Maintenance Treatment | Phase 3 | 2024-07-01 |
| Completed | Mindfulness-Based Intervention Targeting Psychological Capital to Reduce Job Burnout Among Nurses Burnout, Psychological Capital, Mental Health | N/A | 2024-05-01 |
| Not Yet Recruiting | High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases Lung Cancer, Nonsmall Cell | Phase 2 | 2024-04-01 |
| Unknown | Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategy Esophageal Cancer, Radiation Therapy, Immunotherapy | Phase 2 / Phase 3 | 2022-07-01 |
| Completed | Identification of the Optimal Functional Lymphatic Vessel for Lymphaticovenous Anastomosis Lymphedema | — | 2022-01-01 |
| Recruiting | 18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 2 | 2022-01-01 |
| Unknown | Adjuvant Chemotherapy and Anti-PD-1 Antibody in Patients With Stage IIIC2-IVB Cervical Cancer Cervical Cancer | Phase 2 | 2021-05-01 |
| Unknown | First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC Small Cell Lung Carcinoma | Phase 2 | 2020-05-01 |
| Completed | Optimal Incision Site Design for Lymphaticovenular Anastomosis in Extremity Lymphedema Lymphedema | — | 2020-01-01 |
| Completed | S1 Plus Anlotinib in Treating Patients With Refractory or Relapsed Small-cell Lung Cancer Small Cell Lung Cancer Recurrent | Phase 2 | 2019-03-01 |
| Unknown | Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Sma Non Small Cell Lung Cancer Metastatic | Phase 2 / Phase 3 | 2019-03-01 |
| Unknown | Pyrotinib After Trastuzumab-based Adjuvant Therapy in Patients With HER2-positive Breast Cancer Breast Cancer | Phase 2 | 2019-01-01 |
| Unknown | CT-Guided Adaptive Radiation Therapy Combine With Anti-PD-1 Antibody Adjuvant Immunotherapy for Thoracic Cance Thoracic Malignancies | Phase 2 | 2018-11-14 |
| Unknown | A Multi-center Study for Eradication of Refractory Helicobacter Pylori Gastritis | N/A | 2016-06-01 |
| Unknown | Paclitaxol Every 2 Week Versus Paclitaxol Every 1 Week in the Adjuvant Treatment of Breast Cancer Breast Cancer, Paclitaxel, Epirubicin | N/A | 2013-05-01 |
| Completed | Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 1 / Phase 2 | 2012-02-01 |
| Completed | Esophageal Fistula After Anterior Cervical Decompression and Fusion Esophageal Fistula | — | 2010-01-01 |
| Unknown | Warming Contrast Media for Hysterosalpingography Infertility | Phase 1 / Phase 2 | 2010-01-01 |
| Completed | Medical Abortion for Emergency Contraception Failure Emergency Contraception, Abortion, Induced | N/A | 2004-10-01 |